IBDEI2T5 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44784,1,3,0)
 ;;=3^Drug Phototoxic Response
 ;;^UTILITY(U,$J,358.3,44784,1,4,0)
 ;;=4^L56.0
 ;;^UTILITY(U,$J,358.3,44784,2)
 ;;=^5009214
 ;;^UTILITY(U,$J,358.3,44785,0)
 ;;=L23.9^^170^2236^6
 ;;^UTILITY(U,$J,358.3,44785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44785,1,3,0)
 ;;=3^Dermatitis,Allergic Contact,Cause Unspec
 ;;^UTILITY(U,$J,358.3,44785,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,44785,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,44786,0)
 ;;=L30.9^^170^2236^21
 ;;^UTILITY(U,$J,358.3,44786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44786,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,44786,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,44786,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,44787,0)
 ;;=L24.9^^170^2236^16
 ;;^UTILITY(U,$J,358.3,44787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44787,1,3,0)
 ;;=3^Dermatitis,Irritant Contact,Cause Unspec
 ;;^UTILITY(U,$J,358.3,44787,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,44787,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,44788,0)
 ;;=L30.0^^170^2236^17
 ;;^UTILITY(U,$J,358.3,44788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44788,1,3,0)
 ;;=3^Dermatitis,Nummular
 ;;^UTILITY(U,$J,358.3,44788,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,44788,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,44789,0)
 ;;=L23.2^^170^2236^4
 ;;^UTILITY(U,$J,358.3,44789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44789,1,3,0)
 ;;=3^Dermatitis,Allergic Contact d/t Cosmetics
 ;;^UTILITY(U,$J,358.3,44789,1,4,0)
 ;;=4^L23.2
 ;;^UTILITY(U,$J,358.3,44789,2)
 ;;=^5009117
 ;;^UTILITY(U,$J,358.3,44790,0)
 ;;=L24.3^^170^2236^12
 ;;^UTILITY(U,$J,358.3,44790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44790,1,3,0)
 ;;=3^Dermatitis,Irritant Contact d/t Cosmetics
 ;;^UTILITY(U,$J,358.3,44790,1,4,0)
 ;;=4^L24.3
 ;;^UTILITY(U,$J,358.3,44790,2)
 ;;=^5009129
 ;;^UTILITY(U,$J,358.3,44791,0)
 ;;=L27.2^^170^2236^1
 ;;^UTILITY(U,$J,358.3,44791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44791,1,3,0)
 ;;=3^Dermatitis d/t Ingested Food
 ;;^UTILITY(U,$J,358.3,44791,1,4,0)
 ;;=4^L27.2
 ;;^UTILITY(U,$J,358.3,44791,2)
 ;;=^5009146
 ;;^UTILITY(U,$J,358.3,44792,0)
 ;;=L21.8^^170^2236^20
 ;;^UTILITY(U,$J,358.3,44792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44792,1,3,0)
 ;;=3^Dermatitis,Seborrheic
 ;;^UTILITY(U,$J,358.3,44792,1,4,0)
 ;;=4^L21.8
 ;;^UTILITY(U,$J,358.3,44792,2)
 ;;=^303310
 ;;^UTILITY(U,$J,358.3,44793,0)
 ;;=L20.89^^170^2236^7
 ;;^UTILITY(U,$J,358.3,44793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44793,1,3,0)
 ;;=3^Dermatitis,Atopic
 ;;^UTILITY(U,$J,358.3,44793,1,4,0)
 ;;=4^L20.89
 ;;^UTILITY(U,$J,358.3,44793,2)
 ;;=^5009112
 ;;^UTILITY(U,$J,358.3,44794,0)
 ;;=E08.622^^170^2236^23
 ;;^UTILITY(U,$J,358.3,44794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44794,1,3,0)
 ;;=3^Diabetes d/t Underlying Condition w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,44794,1,4,0)
 ;;=4^E08.622
 ;;^UTILITY(U,$J,358.3,44794,2)
 ;;=^5002535
 ;;^UTILITY(U,$J,358.3,44795,0)
 ;;=T81.31XA^^170^2236^26
 ;;^UTILITY(U,$J,358.3,44795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44795,1,3,0)
 ;;=3^Disruption External Surgical Wound NEC,Init Encntr
 ;;^UTILITY(U,$J,358.3,44795,1,4,0)
 ;;=4^T81.31XA
 ;;^UTILITY(U,$J,358.3,44795,2)
 ;;=^5054470
 ;;^UTILITY(U,$J,358.3,44796,0)
 ;;=L26.^^170^2236^8
 ;;^UTILITY(U,$J,358.3,44796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44796,1,3,0)
 ;;=3^Dermatitis,Exfoliative
